Regen-COV(casirivimab/imddevimab) is the first medicine to prevent COVID-19, it is an injectable monoclonal antibody combo blocks SARS-CoV-2 from entering the cells. It is already authorized to treat mild to moderate COVID-19 in outpatients age 12 or older at high risk of severe illness. This includes patients with diabetes age 65 or older or even with a BMI over 25. Now consider Regen-COV for PROPHYLAXIS in these same high-risk patients who are exposed and Unvaccinated or vaccinated, not fully vaccinated or vaccinated, but not expected to mount an adequate immune response. Consult your pharmacist for more information. Do NOT take any medication without your Physician authorized it for you.
Regen-COV(casirivimab/imddevimab) is the first medicine to prevent COVID-19, it is an injectable monoclonal antibodycombo blocks SARS-CoV-2 from entering the cells. It is already authorized to treat mild to moderate COVID-19 inoutpatients age 12 or older at high risk of severe illness. This includes patients with diabetes age 65 or older or evenwith a BMI over 25. Now consider Regen-COV for PROPHYLAXIS in these same high risk patients who are exposedand Unvaccinated or vaccinated, not fully vaccinated or vaccinated, but not expected to mount anadequate immune response.Consult your Pharmacist for more information. Do NOT take any medication without your Physician authorized it for you.
